BRIEF published on 05/21/2025 at 13:05, 1 year 2 months ago Moderna Withdraws BLA Submission for Combo Vaccine FDA Moderna MRNA Vaccine BLA Withdrawal Flu/COVID-19 Vaccine
PRESS RELEASE published on 05/21/2025 at 13:00, 1 year 2 months ago Moderna Provides Update on BLA Submission for Combination Vaccine Against Influenza and COVID-19 Moderna voluntarily withdraws BLA for flu/COVID vaccine mRNA-1083 for adults 50+, plans resubmission later this year post efficacy data from mRNA-1010 trial Withdrawal Moderna Vaccine Efficacy Data BLA
BRIEF published on 05/08/2025 at 13:05, 1 year 3 months ago Moderna sera présenté à la conférence sur les décisions stratégiques de Bernstein Événement Pour Les Investisseurs Technologie De L'ARNm Accès À La Webdiffusion Moderna, Inc. Rediffusion De La Conférence
BRIEF published on 05/08/2025 at 13:05, 1 year 3 months ago Moderna to Showcase at Bernstein's Strategic Decisions Conference MRNA Technology Investor Event Webcast Access Moderna, Inc. Conference Replay
PRESS RELEASE published on 05/08/2025 at 13:00, 1 year 3 months ago Moderna to Present at Upcoming Bernstein's 41st Annual Strategic Decisions Conference (SDC) on May 29, 2025 Moderna, Inc. to participate in Bernstein's 41st Annual Strategic Decisions Conference. Learn about their mRNA technology advancements in medicine Investor Conference COVID-19 Vaccine MRNA Technology Moderna Bernstein's SDC
BRIEF published on 05/01/2025 at 12:35, 1 year 3 months ago Moderna publie ses résultats financiers du premier trimestre 2025, mettant en évidence les ajustements stratégiques Résultats Financiers Oncologie Moderne Vaccin Contre Le Covid-19 Coûts D'exploitation
BRIEF published on 05/01/2025 at 12:35, 1 year 3 months ago Moderna Reports Q1 2025 Financial Results Highlighting Strategic Adjustments Financial Results Operating Costs COVID-19 Vaccine Oncology Moderna
PRESS RELEASE published on 05/01/2025 at 12:30, 1 year 3 months ago Moderna Reports First Quarter 2025 Financial Results and Provides Business Updates Moderna, Inc. reports Q1 2025 revenues of $0.1B with GAAP net loss of $(1.0)B. Reiterates 2025 revenue forecast of $1.5-$2.5B, cost reduction plan, and product advancements Revenues Forecast Moderna Q1 2025 GAAP
BRIEF published on 04/10/2025 at 13:05, 1 year 4 months ago Moderna to Announce Q1 2025 Financial Results in Early May Financial Results Webcast MRNA Technology Moderna Q1 2025
BRIEF published on 04/10/2025 at 13:05, 1 year 4 months ago Moderna annoncera ses résultats financiers du premier trimestre 2025 début mai Résultats Financiers Webcast Moderne Technologie De L'ARNm T1 2025
Published on 08/13/2026 at 17:55, 1 hour 37 minutes ago Alset AI Announces Agreement to Sell 9.9% Interest in Lyken AI Computing to FingerMotion
Published on 08/13/2026 at 14:31, 5 hours 1 minute ago Wi2Wi Announces Strategic Equipment Investments to Expand Production Capacity
Published on 08/13/2026 at 14:15, 5 hours 17 minutes ago Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th
Published on 08/13/2026 at 14:00, 5 hours 32 minutes ago AEONIAN Expands Koocanusa Copper Project to Approximately 412 Km(2); Fieldwork Underway Across Four New Target Areas
Published on 08/13/2026 at 14:00, 5 hours 32 minutes ago Adcore Reports Q2 2026 Results: Gross Margin Expands to 51% as Revenue Grows 10% to CAD$7.2 million and North America Rebounds 27% to CAD$1.5 million
Published on 08/13/2026 at 18:17, 1 hour 14 minutes ago EQS-Adhoc: Energiekontor AG: Energiekontor adjusts earnings guidance for the 2026 financial year
Published on 08/13/2026 at 18:00, 1 hour 32 minutes ago Deutsche EuroShop reports good operational performance in the first half of 2026 and confirms its forecast
Published on 08/13/2026 at 17:50, 1 hour 41 minutes ago EQS-Adhoc: NFON AG updates guidance for the 2026 financial year
Published on 08/13/2026 at 17:23, 2 hours 8 minutes ago EQS-Adhoc: Sirma Group JSC: Signing of Agreements to Acquire a Majority Stake in Jucari Global Pty Ltd
Published on 08/13/2026 at 18:00, 1 hour 32 minutes ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 2 days 1 hour ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 2 days 1 hour ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 3 days 1 hour ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 3 days 1 hour ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
